Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03030599 · ClinicalTrials.gov registry record · Phase 3
A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
A Phase 3 study, sponsored by Jazz Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 201
- Enrollment target
NCT03030599 is a Phase 3 study that has completed, run by Jazz Pharmaceuticals. The registered enrollment target is 201 participants.
The verdict
NCT03030599, a Phase 3 study, has completed, sponsored by Jazz Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 201 participants
- Enrollment target
Study Summary
This is a double-blind, placebo-controlled, randomized-withdrawal, multicenter study of the efficacy and safety of JZP-258.
Interventions
- OTHER Placebo
- DRUG JZP-258
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2017-03-14 |
| Est. Completion | 2019-07-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03030599
The ClinicalTrials.gov registry entry for NCT03030599 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jazz Pharmaceuticals, which has 128 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03030599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03030599 about?
NCT03030599 is a clinical study titled "A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy". This is a double-blind, placebo-controlled, randomized-withdrawal, multicenter study of the efficacy and safety of JZP-258.
What is the current status of trial NCT03030599?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 201 participants. The study started on 2017-03-14. Estimated completion is 2019-07-10.
What interventions are being tested in trial NCT03030599?
The interventions under investigation include: Placebo (OTHER), JZP-258 (DRUG).
Who is sponsoring clinical trial NCT03030599?
This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.